Recent advances of engineered bacteria for therapeutic applications

Area of Science:

• Synthetic biology and genetic engineering of bacterial systems for therapeutic applications.

Background:

• Engineered bacteria are versatile biotherapeutic platforms, but their efficacy is often limited.
• Synthetic biology advancements enable overcoming intrinsic bacterial limitations through computational modeling and genetic circuit design.

Purpose of the Study:

• To systematically examine recent advances in engineered bacteria development and testing across different organs based on tissue specificity.
• To summarize the therapeutic roles of engineered bacteria in tumor treatment and metabolic disorder management.
• To outline advanced technologies for optimizing the clinical efficacy of engineered bacterial agents.

Main Methods:

• Review of recent advancements in synthetic biology for bacterial deconstruction and genetic circuit design.
• Analysis of tissue-specific engineered bacterial systems across various organs.
• Summary of therapeutic applications in oncology and metabolic disorders.

Main Results:

• Engineered bacteria demonstrate enhanced spatiotemporal precision, improved biosafety, and scalable production.
• Applications extend to vaccine development and tumor microenvironment modulation.
• System-level optimization is crucial for enhancing clinical efficacy.

Conclusions:

• Engineered bacteria represent a promising therapeutic strategy with potential for broad clinical impact.
• Continued advancements in genetic engineering and system-level optimization will further enhance their therapeutic efficacy.